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suppression of gingival nK cells in 
Precancerous and cancerous stages 
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humanized Mice
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1Division of Oral Biology and Oral Medicine, School of Dentistry and Medicine, University of California, Los Angeles, 
Los Angeles, CA, United States, 2Department of Surgery, David Geffen School of Medicine, University of California, 
Los Angeles, Los Angeles, CA, United States, 3Department of Tumor Immunology, UCLA School of Dentistry and Medicine,  
University of California, Los Angeles, Los Angeles, CA, United States, 4The Jonsson Comprehensive Cancer Center, 
University of California, Los Angeles, Los Angeles, CA, United States
The aim of our studies is to determine the dynamics of natural killer (NK) cell modula-
tion in gingivae in precancerous and cancerous stages of pancreatic and oral cancers 
in P48+/Cre;LSL-KRASG12D (KC) mice carrying a pancreas-specific oncogenic Kras 
mutation and BLT-humanized mice. Wild type and KC mice fed with control diet (CD) 
or high-fat calorie diet (HFCD), and the pancreatic and oral tumor-bearing human-
ized BLT (hu-BLT) mice were used to determine precancerous and cancer induced 
changes in numbers and function of gingival NK cells. Increased numbers of PanIN 
lesions and the greatest score of inflammation in pancreas of KC mice fed with CD 
and HFCD co-related with significant decline in percentages of circulating and gingival 
NK cells, lack of DX5+ NK expansion and increased secretion of IFN-γ and IL-6 after 
culture. At the malignant stage of pancreatic cancer, hu-BLT tumor-bearing mice had 
the lowest secretion of IFN-γ from cells dissociated from the gingival tissues as com-
pared to those from non-tumor-bearing mice. Injection of NK cells into tumor-bearing 
mice increased IFN-γ secretion, and the secretion was similar or higher than those 
obtained by gingival cells from non-tumor-bearing hu-BLT control mice. The highest 
increase in IFN-γ secretion was observed when tumor-bearing mice were fed with AJ2 
probiotic bacteria and injected with the NK cells. Along with an increase in secretion 
of IFN-γ, injection of NK cells in the presence and absence of feeding with AJ2 in 
pancreatic tumor-bearing mice increased percentages of CD45+ and CD3+ T cells in 
oral gingival cells. Similar results were observed with oral tumors. In conclusion, these 
results indicated that oral cavity may mirror systemic disease and provide a rationale 
for why cancer patients may be prone to suffer from diverse oral pathologies.
Keywords: nK cells, iFn-γ, Kras, hu-BlT mice, gingiva
sUMMarY
What is already known about this subject?
•	 Patients with cancer suffer from a variety of oral diseases but the underlying mechanisms for oral 
pathologies are not known.
•	 Immune cells are functionally inactivated in cancer patients but the dynamics of immune 
modulation during precancerous and cancerous stages of pancreatic cancer is not known.
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What are the new findings?
•	 Loss of NK  cell numbers and lack of NK expansion and 
function within the circulating and oral gingival tissues after 
culturing at both the precancerous and cancerous stages of 
pancreatic cancer using KC and BLT-humanized mice models, 
respectively.
•	 Both genetic and environmental factors can clearly contribute 
to the loss of NK cells due to the lack of NK expansion.
•	 Steps that can be taken in order to reverse decreased NK 
and T cell function within the oral gingival tissues.
•	 At the precancerous stage of tumorigenesis, there is a sig-
nificant elevation in the secreted inflammatory cytokines by 
gingival cells in the absence of NK expansion; however, at the 
cancerous stage, there is a severe decrease in IFN-γ secretion 
by the gingival cells from tumor-bearing mice which is restored 
by a single injection of super-charged NK cells in the presence 
and absence of feeding with AJ2 probiotic bacteria.
•	 Mouse models used are the state of the art technology in cancer 
research which allowed us to evaluate the disease progression 
in relevant pre-clinical models resembling closely to human 
disease.
How might it impact on clinical practice in the foreseeable 
future?
•	 Oral cavity mirrors systemic disease and it is an accessible site 
which can be used for an early detection method for disease 
activity and progression.
•	 Loss of NK  cells in gingivae is likely to contribute to many 
well-documented oral pathologies in cancer patients.
•	 Immunotherapy is one of the most important means of can-
cer treatment, therefore, methodologies used in this paper 
provide ways to not only inhibit tumor growth and metastasis 
but also to prevent or reverse oral diseases since IFN-γ is the 
most important cytokine known to drive differentiation of the 
tumor and healthy cells.
•	 By understanding the underlying mechanisms for the inac-
tivation of immune function in gingivae strategies can be 
designed to reverse or treat oral diseases.
inTrODUcTiOn
Natural Killer (NK) cells are large granular lymphocytes that 
function at the interface of innate and adaptive immunity (1). 
NK cells are known to mediate cytotoxicity through preformed 
granules and promote differentiation of cancer stem cells by 
secreted and membrane bound IFN-γ and TNF-α (2–4). The 
majority of murine NK cells express DX5 surface antigen, also 
known as CD49b (5, 6). Moreover, a minor subpopulation of 
T  cells (1–3%) is also found to express DX5 on their surface 
(7–9). We have recently shown that osteoclasts (OCs) are able 
to significantly expand NK cells, and potently increase NK cell 
function (coined as super-charged NK cells) due to their superior 
ability to expand NK  cells to kill and secrete IFN-γ and other 
cytokines allowing for effective targeting of cancer stem cells (10).
Obesity is known to be associated with increased risk of 
various malignancies (11). The tumor incidence among 
animals consuming higher amounts of unsaturated fat is 
shown to be elevated (12). During tumorigenesis high-
unsaturated-fat diets significantly elevated the pancreatic 
neoplasm incidence, whereas the caloric-restricted diets had 
no effect on the neoplasm incidence (13). Excess body weight 
account for approximately a quarter to one-third of cancers of 
the colon, breast, endometrium, kidney, and esophagus (14). 
Obesity leading to intra-pancreatic fatty infiltration has been 
associated with increased risk of pancreatic cancer and its 
precursor lesions (15). Excess adiposity and impaired immune 
function have been described in both humans and genetically 
obese rodents (16).
Natural Killer cells are functionally inactivated in patients 
with a variety of different cancers (17–20) and pancreatic 
ade nocarcinoma patients with high number of NK cells have 
much better prognosis (21). Medium and high cytotoxic activ-
ity of peripheral-blood lymphocytes leads to reduced cancer 
risk, whereas low activity is associated with increased cancer 
risk (17). There is a large gap in our understanding of the role 
of NK  cells in the oral microenvironment during health and 
disease, particularly during either the precancerous or cancer-
ous stages of malignancies. In addition, it is also unknown 
whether genetic or environmental factors, or both, contribute 
to the inactivation of NK cell function in the oral cavity, aid-
ing in the generation of oral pathologies seen in many cancer 
patients (22, 23).
The association between periodontal disease and pancreatic 
cancer has been shown in several studies (24). Poor dental 
health and tooth loss has been associated with increased risks 
of oral, esophageal, and gastric and pancreatic cancers (25). The 
relationship between obesity and poor dental health including 
periodontal disease has also been demonstrated previously 
(26). Thus, oral and pancreatic cancers similar to other cancer 
types can predispose patients to a variety of oral diseases. 
Although the relationship between obesity, cancer and oral 
diseases has clearly been established previously, the underlying 
defects governing the oral manifestations of systemic disease, 
in particular number and functional characteristics of NK cells 
within oral gingival cells have not been delineated and is 
the focus of this paper. Although the relationship between NK cells 
and oral diseases has been addressed in a very few publications 
(27), there is a significant gap in our knowledge regarding the role 
of NK cells in obesity and cancer-related oral disease progression.
The main genes mutated in pancreatic cancer include 
KRAS2, p16/CDKN2A, TP53, and SMAD4/DPC4 which are 
accompanied by a substantial genomic and transcriptomic 
alterations that facilitate cell cycle deregulation, tumor cell 
survival, invasion, and metastases (28, 29). The BLT-humanized 
mouse (hu-BLT) represents the most advanced humanized 
mouse model generated thus far (30). Generation of hu-BLT 
mice has been described previously (31–33). The hu-BLT model 
is the only known humanized mouse model to display mucosal 
immunity (34). Due to similarities between the function and 
number of NK cells in hu-BLT mice and cancer patients, this 
model is the best preclinical model to study the underlying 
mechanisms that govern tumor-mediated NK cell inactivation 
and decrease in their numbers.
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We have previously demonstrated that AJ2, a combination 
of probiotic bacteria selected for their increased survival under 
adverse conditions of temperature and acidity have the ability to 
induce balanced secretion of IFN-γ and IL-10 by the NK cells 
thereby increasing differentiation of tumor cells resulting in 
significantly decreased tumor growth (35). In this paper, we 
have extended our previous findings to present in  vivo data 
demonstrating AJ2 effect on NK  cell mediated inhibition of 
tumor growth.
The data presented in this paper are significant in many 
ways. First, we are able to provide evidence for the loss of 
DX5+ NK cell numbers in the oral gingival tissues at both the 
precancerous and cancerous stages of tumorigenesis which is 
likely to contribute many well-documented oral pathologies in 
cancer patients. Second, we demonstrate that both genetic and 
environmental factors can clearly contribute to the loss of these 
cells, and third the steps that can be taken in order to reverse or 
decrease inactivation of NK cell function within the oral gingival 
tissues. In addition, we demonstrate that at the precancerous 
stage of tumorigenesis, there is a significant elevation in the 
secreted inflammatory cytokines by gingival cells; however, at 
the cancerous stage, there is a severe decrease in IFN-γ secretion 
by the gingival cells from tumor-bearing mice which is restored 
by a single injection of super-charged NK cells in the presence 
and absence of feeding with AJ2. Thus, oral cavity mirrors sys-
temic disease and it can be used as an early detection method to 
determine disease progression.
MaTerials anD MeThODs
conditional Kras(g12D) Mouse Model
To study the effect of a high caloric diet on immune func-
tion during pancreatic cancer development, the conditional 
KRAS(G12D) model was used (36). After weaning, offsprings 
of LSL-KRAS(G12D) and p48-Cre (or PDX-1-Cre) mice were 
fed either a high-fat calorie diet (HFCD) or a control diet (CD) 
for 3–4  months (Figure  1A). Afterward, animals were eutha-
nized and the entire pancreas, visceral adipose tissues, and other 
organs were harvested. Formalin-fixed, paraffin-embedded 
tissues were sectioned (4 µm) and stained with H&E. Sections 
of pancreatic tissues were histologically evaluated by a gastroin-
testinal pathologist for the presence and stage of murine PanIN 
lesions (mPanIN) as described previously (37). Animal studies 
were approved by the Chancellor’s Animal Research Committee 
of the University of California, Los Angeles in accordance with 
the NIH Guide for the Care and Use of Laboratory Animals 
(ARC # 2012-101-13A and 2011-118).
experimental Diets
The diets were obtained from Dyets, Inc., Pennsylvania 
(Table  1). A slightly modified AIN-76A purified rodent diet 
served as a CD. Compared to the CD our HFCD has increased 
caloric content (4,536 vs. 3,726 kcal/kg), which stems from an 
increase in corn oil-based fat content (1,800 vs. 450 kcal/kg). 
While ~12% of the total calories in the AIN-76A CD come from 
fat, about 40% of total caloric intake in the HFCD stems from 
fat. The corn oil contains about 60% omega-6 polyunsaturated 
fatty acids (linoleic acid), saturated fatty acids (10.8% palmi-
tic, 2.1% stearic), mono-unsaturated fatty acids (26.5% oleic), 
and small amounts of omega-3 polyunsaturated fatty acids 
(0.6% linolenic). Importantly, the amount of sucrose, salts, and 
vitamins are kept identical in both diets. To compensate for 
the increase in corn oil, we reduced the amount of cornstarch 
in the HFCD accordingly. The diets were handled under low 
light conditions and stored at −20°C. The diets were replaced 
twice weekly. The stability of the fatty acids in the diets was 
regularly monitored by the UCLA Nutritional Biomarker and 
Phytochemistry Core.
genotyping analysis
Before randomization to the diets the presence of the KrasG12D 
and Cre allele were determined by PCR analysis of genomic 
DNA, as described elsewhere, obtained from tail biopsies (39). 
Animals with both the KrasG12D and Cre allele were designated as 
mutant (KRAS+/G12D) and animals with neither the KrasG12D nor 
the Cre allele were deemed wildtype (KRAS+/+). At the end of the 
study at sacrifice, the successful excision–recombination events 
were confirmed by PCR by the presence of a single LoxP site in 
the pancreas as described elsewhere (39).
cell lines, reagents, and antibodies
RPMI 1640 supplemented with 10% fetal bovine serum (FBS) 
was used for the cultures of gingiva cells, oral tumors and 
ST63 tumors. DMEM media were used to culture pancreatic 
tumors. Recombinant IL-2 was obtained from NIH-BRB. Flow 
antibodies were purchased from Biolegend (San Diego, CA, 
USA). AJ2 is a combination of eight different strains of Gram-
positive probiotic bacteria (Streptococcus thermophilus, Bifi-
dobacterium longum, Bifidobacterium breve, Bifidobacterium 
infantis, Lactobacillus acidophilus, Lactobacillus plantarum, 
Lactobacillus casei, and Lactobacillus bulgaricus) used to induce 
differentiation of stem cells and are selected for their superior 
ability to induce optimal secretion of both pro-inflammatory 
and anti-inflammatory cytokines in NK cells. In addition, each 
strain was grown, and specific colonies were selected after 
three rounds of sub-cloning based on the ability to withstand 
environmental pressures such as temperature and acidity (35).
generation of super-charged nK cells
Human purified and hu-BLT enriched NK cells were activated 
with rh-IL-2 (1,000  U/ml) and anti-CD16mAb (3ug/ml) for 
18–20 h before they were co-cultured with osteoclasts and soni-
cated AJ2. The culture media were refreshed with rh-IL-2 every 
3 days (10). For sonication, AJ2 was weighed and re-suspended 
in RPMI 1640 Medium containing 10% FBS at a concentration of 
10 mg/ml. The bacteria were thoroughly vortexed, then sonicated 
on ice for 15 s, at 6–8 amplitudes. Sonicated samples were then 
incubated for 30 s on ice. After every five pulses, a sample was 
taken to observe under the microscope until at least 80% of 
cell walls were lysed. It was determined that approximately 20 
rounds of sonication/incubation on ice were required to achieve 
complete sonication. Finally, the sonicated samples (sAJ2) were 
aliquoted and stored in a −80°C freezer until use.
FigUre 1 | Decreased cytotoxicity and lower percentages of DX5+ NK cells in circulating PBMCs from WT mice fed with HFCD and KC mice fed with control diet 
(CD) and high-fat calorie diet (HFCD) as compared to WT mice fed with CD. Flow chart demonstrating group division of the WT and Conditional KC mice according 
to the type of diet fed is shown in this figure. Offspring of LSL-KRAS(G12D) and PDX-1-Cre mice were fed either a CD or HFCD for 3–4 months. Food intake and 
body weight of each animal were measured weekly (a). PBMCs were isolated from the peripheral blood of the mice and cultured with IL-2 (10,000 U/mL) for 7 days 
before they were used as effectors against 51Cr labeled ST63 cells at various effector to target ratios in a standard 4-h 51Cr release assay. The lytic units (LUs) 30/106 
cells were determined using the inverse number of cells required to lyse 30% of the ST63 cells ×100 (B). T cells were positively selected from splenocytes and were 
cultured with IL-2 (1,000 U/mL) for 7 days before they were used as effectors against 51Cr labeled ST63 cells at various effector to target ratios in a standard  
4-h 51Cr release assay. The LUs were determined as described in Fig. 1B (c). PBMCs were isolated from the peripheral blood of the mice and cultured with IL-2 
(10,000 U/ml) for 7 days and surface expression of DX5 on CD45+ immune cells were determined (n = 2) (D). NK cells were purified from splenocytes obtained 
from WT and KC mice fed with CD or HFCD, and cultured at (1 × 106 cells/ml) before they were treated with IL-2 (10,000 U/ml) for 7 days. After incubation,  
NK cells were counted and equal numbers of cells from each group were cultured with 51Cr labeled tumor cells in a standard 4-h 51Chromium release assay.  
The lytic units (LUs) 30/106 cells were determined using the inverse number of cells required to lyse 30% of the ST63 cells×100 (e).
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implantation of human Oral and 
Pancreatic Tumors in humanized Mice
NOD.CB17-Prkdcscid/J and NOD.Cg-Prkdcscid Il2rgtm1Wjl/
Ss′ (NSG lacking T, B, and NK  cells) were purchased from 
Jackson Laboratory and maintained in the animal facilities. 
Humanized-BLT (hu-BLT; human bone marrow/liver/thymus) 
mice were prepared on NSG background as previously described 
in the core facility (10, 31, 40). To establish orthotopic tumors, 
mice were first anesthetized with ketamine (100 mg/kg) and/or 
xylazine (10 mg/kg), and then the pancreas was exposed through 
an abdominal incision (laparotomy). MIA PaCa-2 (MP2) stem-
like/poorly differentiated pancreatic tumor cells (35, 41) were 
then transferred by direct injection of a single-cell suspension 
mixed with 10 µl HC Matrigel (Corning, NY, USA) (0.5 × 106 cells 
into hu-BLT mice) into the pancreas, secured by a 7-0 prolene 
suture. For oral tumor, oral squamous carcinoma stem cells 
(OSCSCs) as characterized previously (4) were injected directly 
in the floor of mouth as a single-cell suspension mixed with 
10 µl HC Matrigel. Immediately prior to tumor cells injection, 
5.0 mg/kg carprofen was injected subcutaneously, and the injec-
tion was repeated every 24 h for 48 h.
After tumor implantation, all mice were monitored at least 
twice weekly for disease progression and for overall signs of 
morbidity such as ruffled fur, hunched posture, and inactivity. 
7–10  days after the surgery, selected hu-BLT mice received 
1.5  ×  106 human or hu-BLT OC-expanded NK  cells via tail 
vein injection (10). 5 billion AJ2 was dissolved in milk and fed 
orally 2  weeks before tumor implantation every 48  h, and the 
feeding were continued until the day of sacrifice. Control mice 
received milk without the bacteria. Gingiva tissue and tumors 
were harvested from mice at the end of the experiment following 
orthotropic tumor implantation when tumor size reached 1 cm 
diameter as assessed by abdominal palpation and/or signs of 
morbidity could be observed.
Preparation of single cell suspensions  
of gingival Tissues, PBMc, and spleen
To prepare a single-cell suspension of mouse gingival tissues 
for subsequent analyses, animals were sacrificed and gingival 
tissue from the palatal site was harvested. The gingival tissue was 
immediately cut into 1 mm3 pieces and placed into a digestion 
buffer containing 1 mg/ml collagenase II, 10 U/ml DNAse I, and 
1% bovine serum albumin in DMEM, and incubated for 20 min 
at 37°C oven on a 150 rpm shaker. After digestion, the samples 
were filtered through a 40  µm cell strainer and centrifuged at 
1,500 rpm for 10 min at 4°C. The pellet was re-suspended in DMEM 
and cells counted. Tissue dissociation procedure as described for 
gingiva was followed to prepare single-cell suspensions of 
pancreatic tumors and oral tumors obtained from hu-BLT mice. 
Peripheral blood  was obtained by cardiac puncture, and PBMCs 
were isolated as described previously (42, 43).
nK and T cell Purifications
Natural Killer cell purification was conducted using negative 
selection kit and T  cell purification using positive selection 
kit from splenocytes as recommended by the manufacturer 
(Stem-cells Technologies, Canada). RPMI 1640 supplemented 
with 10% FBS with IL–2 (100 U/ml) was used for the cul-
tures of T cells. PBMCs and NK  cells were treated with IL-2 
(1,000  U/ml). Gingiva cell culture media for WT and KC 
mice was supplemented with 10,000  U/ml of IL-2, whereas 
gingival cell culture from hu-BLT mice was supplemented with 
1,000 U/ml IL-2.
cell surface receptor staining
Staining was performed by adding the antibodies as described 
previously (44). Briefly, cells were washed twice with ice-cold 
PBS containing 1% BSA. Predetermined optimal concentrations 
of specific human monoclonal antibodies were added to 1 × 105 
to 3 × 105 cells in 50 µl of cold-BSA and cells were incubated on 
ice for 30 min. Thereafter, cells were washed in cold PBS–BSA 
and brought up to 500 µl with PBS–BSA. Flow cytometry analysis 
was performed using Beckman Coulter Epics XL cytometer 
(Brea, CA) and results were analyzed in FlowJo vX software 
(Ashland, OR, USA). Minimum of 10,000 events were run for all 
flow cytometric analysis.
51cr release cytotoxicity assay
The 51Cr release assay was performed as described previously 
(45). Briefly, different numbers of effector cells were incubated 
with 51Cr–labeled target cells. After a 4 h incubation period the 
supernatants were harvested from each sample and counted for 
released radioactivity using the gamma counter. The percentage 
specific cytotoxicity was calculated as follows:
 
% Cytotoxicity
Experimental cpm spontaneous cpm
Total cpm sp
=  
−
− ontaneouscpm  
LU 30/106 is calculated by using the inverse of the number of 
effectors needed to lyse 30% of tumor target cells ×100.
elisa
Single ELISAs were performed as described previously (43). To 
analyze and obtain the cytokine and chemokine concentration, a 
standard curve was generated by either two- or threefold dilution 
of recombinant cytokines provided by the manufacturer.
statistical analysis
An unpaired, two-tailed Student’s t-test was performed for the 
statistical analysis. One-way ANOVA with a Bonferroni post-
test was used to compare the different groups. n represents the 
number of mice used for each experiment. The following symbols 
represent the levels of statistical significance, *p < 0.05; **p < 0.01; 
***p < 0.001, and ****p < 0.0001.
resUlTs
increased numbers of Panin lesions in 
Pancreas in Kc Mice Fed with hFcD
KC mice fed with HFCD exhibited significantly more advanced 
precancerous PanIN-2 and -3 lesions when compared to KC 
mice on CD (Table 1). No invasive pancreatic ductal adeno-
carcinoma could be found in KC mice fed with either CD or 
TaBle 1 | Increased numbers of PanIN lesions in pancreas of KC mice fed with control diet (CD) and high-fat calorie diet (HFCD).
Panin1a Panin1b Panin-2 Panin-3 normal ducts (nD) Total acinar cell loss inflammation Fibrosis Pancreatitis score
WT/CD 0 0 0 0 100 100 0 0 0 0
WT/HF 0 0 0 0 100 100 0 1 0 1
KC/CD 15 8 2 0 75 100 1 1 1 3
KC/HF 30 20 6 4 40 100 2 2 1 5
Formalin-fixed, paraffin-embedded tissues were sectioned (4 mm) and stained with H&E. Six to eight sections (100 µm apart) of pancreatic tissues were histologically evaluated by a 
gastrointestinal pathologist blinded to the experimental groups. Murine PanIN lesions (mPanIN) were classified according to histopathologic criteria as recommended previously (37). 
To quantify PanIN lesions, the total number of ductal lesions and their grade were determined. About 100 pancreatic ducts were analyzed for each animal. The relative proportion 
of each PanIN lesion to the overall number of analyzed ducts was recorded for each animal. For the assessment of pancreatic inflammation, full histologic cross sections of each 
pancreas were graded using a semi-quantitative scoring system, as previously described (38). Pancreatic inflammation was given an index score (0–12) reflecting the sum of scores 
for acinar loss, lobular inflammation, and fibrosis. Histologic quantification of PanIN lesions and ND in WT mice fed with CD or HFCD in percentage of total ducts were analyzed. 
Pancreatic inflammation was quantified histologically by grading (from 0 to 4) acinar cell loss, inflammatory cell infiltration, and extent of fibrosis, resulting in a cumulative pancreatic 
inflammation score (0–12). Details about the histologic grading were described previously (38).
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HFCD at 3–4  months (Table  1). No pancreatic neoplastic 
lesions were found in WT mice fed with either CD or HFCD. 
In addition, KC mice fed with HFCD had significantly more 
inflammation, acinar cell loss, and increased pancreatitis score 
as compared to KC mice fed with CD (Table 1). The numbers 
of normal ducts within pancreas was much less in KC mice 
fed with HFCD when compared to those fed with CD, and 
pancreatic fibrosis was only observed in KC mice and not in 
WT mice (Table 1).
Decreased Percentages of DX5+ nK cells 
and nK cell cytotoxicity by PBMcs of  
WT and Kc Mice on hFcD
To assess the effect of KRAS mutation and HFCD on NK 
cytotoxicity, we isolated PBMCs from each group of mice, and 
the NK  cell-mediated cytotoxicity and percentages of DX5+ 
immune cells in circulating PBMCs were determined after 
culture for 7  days. ST63 tumor cells were used as target cells, 
ST63 were previously used as specific targets of NK cells (46). 
The following pattern of cytotoxicity against ST63 was observed 
(WT/CD > WT/HFCD > KC/CD > KC/HFCD) (Figure 1B). 
CD3+ T  cells isolated from spleens of each group of mice 
were unable to mediate cytotoxicity against ST63 target cells 
establishing specificity for the function of NK cells (Figure 1C). 
When the percentages of DX5+ cells within CD45+ immune 
cells were determined following 7 days of culture, there was a 
consistent decrease in the percentages of DX5+ cells, which 
demonstrated the following pattern of expression from high 
to low (WT/CD > WT/HFCD > or = KC/CD > KC/HFCD) in 
PBMCs (Figure  1D). NK  cells purified from different groups 
of mice exhibited similar profiles of cytotoxicity as shown for 
PBMCs (Figures 1A,E).
Dynamics of nK cell Modulation and 
cytokine secretion in the gingiva of the 
WT and Kc Mice Fed with cD or hFcD
To evaluate the effect of KRAS mutation and high-fat calorie diet, 
we determined the total numbers of CD45+ immune cells, per-
centage of DX5+ NK cells and total numbers of NK cells in oral 
gingival cells of WT and KC mice on day 0 (Figure 2A) before 
cells were cultured for 7 days (Figure 2B). Since it is difficult to 
determine the fate and number of activated NK cells in vivo in 
the gingival microenvironment during inflammation, possibly 
due to continuous recruitment of the NK cells from the circula-
tion to the site of inflammation and/or increased proliferation 
and/or induction of cell death within gingival microenviron-
ment, we opted to culture the cells dissociated from the gingival 
tissues in vitro and determine the fate of NK cells within the 
gingiva. Equal numbers of cells from each group was cultured 
on day 0 and the total number of cells were counted on day 7 
and found to be equal across different groups (Figure 2B). On 
average, there were no significant differences in the numbers 
of CD45+ immune cells in the oral gingival tissues between 
the 4 groups of mice on day 0 (Figure  2A) or day 7 of cul-
ture (Figure  2B). Moderate increases in the DX5 expressing 
NK cells at time 0 (Figure 2A) in WT mice fed with HFCD, 
KC mice with CD and KC mice fed with HFCD were observed 
when compared to WT mice fed with CD, however, the differ-
ences were not statistically significant. When the percentages 
of DX5+ NK cells were determined after 7 days of gingiva cell 
culture, there was a consistent decline in the percentages of 
DX5+ cells within WT mice fed with HFCD or KC mice fed 
with CD as well as HFCD, exhibiting the following profiles 
(WT/CD > WT/HFCD > KC/CD > KC/HFCD) (Figure 2B), 
the most severe decline was seen in KC mice fed with HFCD 
(Figure 2B). When the total numbers of NK cells were deter-
mined within the populations of CD45+ gingival immune 
cells at time 0, similar numbers were seen in WT mice fed with 
HFCD or KC mice fed with CD as well as HFCD, but these 
three groups had moderately higher numbers of NK cells when 
compared to WT mice fed with CD (Figure  2A). There was 
consistent decline in the numbers of NK cells within WT mice 
fed with HFCD or KC mice fed with CD as well as HFCD on day 
7 after the cell culture, exhibiting the following profiles (WT/
CD > WT/HFCD > KC/CD > KC/HFCD) (Figure 2B). Thus, 
the decrease in the percentages of NK cells when gingival cells 
were cultured with IL-2 for 7 days was not due to the decline 
of total populations of CD45+ immune cells or total numbers 
of cells dissociated from the gingiva (Figure 2B). By contrast 
to the decline of DX5+ NK cells after 7 days of culture, there 
was an increase in IFN-γ (Figure  2C and Table  2) and IL-6 
FigUre 2 | Significant decreases in the numbers of natural killer (NK) cells within gingiva and increases in IFN-γ secretion in KC mice fed with CD and high-fat 
calorie diet after culture Gingival tissues from four groups of mice shown in the figure were harvested and single-cell suspensions were prepared. Percentages of 
CD45 and DX5 expressing immune cells within the gingival cells at the time of sacrifice were determined after staining with the respective PE- and FITC-conjugated 
mouse antibodies and the numbers of CD45+ immune cells, and DX5+ NK cells within CD45+ immune cells were determined for each group of mice. (n = 3)  
(a). Gingival cells (5 × 105/ml) were cultured with IL-2 (10,000 U/ml) for 7 days after which the total number of cells in each were counted, the percentages of CD45 
and DX5 expressing immune cells within the gingival cells were determined and the numbers of CD45+ immune cells and DX5+ NK cells within CD45+ immune 
cells were determined for each group of mice. (n = 3) (B). Gingival cells were cultured as described in panel (B) and their supernantants were harvested and IFN-γ 
(c) and IL-6 (D) secretion were determined using specific ELISAs.
TaBle 2 | Increased cytokines, chemokines, and growth factors and ligands secreted by the gingival cells from KC mice fed with HFCD.
gingiva g-csF Pg/ml il-6 Pg/ml McP-1 Pg/ml MiP-1aPg/ml TnF-a Pg/ml iFn-γ Pg/ml liX Pg/ml
WT/CD 8 0 6 2 0 4 0
WT/HFCD 5 1 6 2 0 3 34
KC/CD 15 2 3 2 0  3 ND
KC/HFCD 41 15 8 18 4.2 22 59
Gingiva tissue was harvested after the mice were sacrificed and single-cell suspension were prepared and cultured in the presence of IL-2 (10,000 U/ml) for 7 days, after which 
supernatants were harvested and secretion of different cytokines, chemokines, and growth factors were determined using multiplex arrays.
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(Figure  2D and Table  2) secretion within the groups when 
compared to WT mice fed with CD and the highest secretion 
was obtained by immune cells cultured from the gingiva of KC 
mice fed with HFCD. Thus, the patterns of IFN-γ secretion 
within the groups were as follows (WT/CD < WT/HFCD < KC/
CD < KC/HFCD). Secretion of IFN-γ is likely from both NK 
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and T  cells within the gingiva. The levels of G-CSF, MIP-1a, 
TNF-α, and LIX were also higher in gingival immune cells from 
KC mice as compared to WT mice (Table 2). We cannot rule 
out any contribution of minor DX5+ population of T cells in 
the observed results.
super-charged nK cells restored iFn-γ 
and il-8 secretion by gingival immune 
cells in Pancreatic Tumor-Bearing Mice 
Fed With and Without aJ2
Humanized BLT mice were reconstituted with more than 
90% of human immune cells in different tissue compartments 
(Figures  3A,B), and had higher percentages of T  cells than 
NK  cells in oral gingiva tissue (Figure  3C). Hu-BLT mice 
were fed with AJ2 probiotic bacteria 2 weeks before they were 
implanted with pancreatic or oral tumors in the pancreas or 
floor of the mouth, respectively, and after 1–2 weeks of tumor 
growth the super-charged NK cells were delivered through the 
tail vein injection and the mice were sacrificed when signs of 
morbidity were evident (Figure 3D). Feeding with AJ2 continued 
throughout the experiment. When the gingival cells from hu-
BLT mice were cultured in the presence of IL-2 and the secretion 
of IFN-γ and IL-8 were determined (Figures 3E–J), there was a 
significantly lower secretion of IFN-γ from the oral gingiva cells 
of pancreatic tumor-bearing mice as compared to non-tumor-
bearing healthy mice (Figures 3E–G). Intravenous injection of 
human (allogeneic) super-charged NK  cells (Figures  3E,F) or 
hu-BLT (autologous) super-charged NK  cells (Figure  3G) in 
pancreatic tumor-bearing mice increased IFN-γ secretion, and 
the levels were further increased when the mice were fed AJ2 
probiotics (Figures 3E–G). Similar results were obtained for the 
secretion of IL-8 from the gingival cells (Figure 3H). We tested 
IL-8 in addition to IFN-γ to demonstrate that a chemokine in 
addition to a cytokine is modulated similarly in tumor-bearing 
hu-BLT mice in the presence and absence of NK injection 
with and without feeding with AJ2. Injection of super-charged 
NK cells in the presence and absence of feeding AJ2 resulted in 
substantially decreased pancreatic tumor weight (Figure  3I). 
Injection of super-charged NK cells in the presence and absence 
of feeding with AJ2 resulted in a similar profile of IFN-γ secretion 
from the gingival cells in oral tumor-bearing mice (Figure 3J) 
and significant reduction in oral tumor weight in hu-BLT mice 
(manuscript in prep).
There was a decrease in the percentages of human CD45+ 
immune cells in oral tumor-bearing hu-BLT mice when 
compared to non-tumor-bearing healthy mice, whereas 
oral tumor-bearing mice injected with super-charged NK 
cells exhibited similar percentages of CD45+ immune cells 
to healthy, non-tumor bearing mice in the gingival tissues 
(Figure  4A). Similarly, there was an increase in percentages 
of T  cells in oral tumor-bearing hu-BLT mice injected with 
super-charged NK  cells (Figures  4A,B). Oral tumor-bearing 
hu-BLT mice fed with AJ2 and injected with super-charged 
NK cells had the highest increase in the CD45+ immune cells 
and this increase was reflected on the increased CD3+ T cells 
(Figures 4A,B).
DiscUssiOn
It is suggested that the oral cavity mirrors systemic health and 
can be used as an accessible and less invasive route to obtain 
samples that could be used to predict or assess disease diagnosis 
and/or prognosis (47, 48). Several investigators have established 
a number of biomarkers which can be used to determine 
either induction or progression of cancer through analysis of 
saliva (48–50). However, little is known about the underlying 
mechanisms which govern changes in the oral microenvironment 
during initiation and progression of cancer. We employed two 
different mouse models for precancerous and cancerous stages of 
pancreatic tumors, and two different types of tumor models, oral 
and pancreatic to determine the effect on oral microenvironment, 
particularly on the function of oral gingival NK  cells, and the 
release of key inflammatory cytokines. Our findings indicate that 
the viability and function of NK cells in gingiva may be greatly 
compromised in cancer patients, and this could be one reason 
why cancer patients suffer from a variety of oral diseases.
At the precancerous stage, KC mice fed with HFCD (51) 
exhibited no change or a slight increase in the circulating DX5+ 
NK cells in PBMCs or gingival cells, followed by KC mice fed with 
CD and WT mice fed with HFCD, and the least were observed in 
WT mice fed with CD at the time of sacrifice. When PBMCs and 
gingival cells were treated with IL-2 and cultured for 7 days, there 
was a significant decrease in the percentages of DX5+ NK cells 
in both PBMCs and gingival cells of KC mice fed with HFCD 
followed by KC mice fed with CD and WT mice fed with HFCD 
as compared to WT mice fed with CD. Percentages of DX5+ 
NK cells were increased in WT mice fed with CD after 7 days of 
culture when compared to those obtained at the time of sacrifice 
whereas much lower increase could be seen in other groups of 
mice and the lowest was seen in KC mice fed with HFCD. In 
contrast to a decrease in NK percentages and decrease or lack of 
expansion of NK  cells in 7-day cultures, there were significant 
increases in cytokine secretion; notably IFN-γ and IL-6 which 
exhibited the inverse profiles to those seen with NK percentages, 
exhibiting the following profiles: KC(HFCD) > KC(CD) > WT(
HFCD) > WT(CD). We have recently shown that NK cells from 
cancer patients when functionally activated expand T cells and, 
consequently, the percentages of NK cells decrease substantially 
whereas healthy donors continue to expand NK cells for a much 
longer time and to a much higher extend (10). Therefore, decrease 
in the percentages of NK cells in KC mice fed with either CD or 
HFCD in 7 days culture can be related to an increase in T cells. In 
addition, when NK cells were sorted out from the spleens of each 
mice, a significant decrease in both cytotoxicity and cytokine 
secretion could be observed in NK cells sorted from KC mice fed 
with HFCD, indicating that the increased levels of IFN-γ is likely 
due to the combination of NK function and potentially increased 
activation of T cells by the NK cells (manuscript submitted). Thus, 
once chronicity of inflammation is established, it is possible that 
expansion of NK cells become limited by the faster expansion of 
T cells. This could be one reason why cancer stem cells survive 
and their numbers increase since there are limited numbers 
of NK cells to decrease the expansion of these cells at the pre-
malignant stage. As long as T cells are capable of differentiating 
FigUre 3 | Continued
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cancer stem cells by their ability to produce IFN-γ, cancer stem 
cells will remain at check and would not expand or metastasize, 
however, once T cell function is also disturbed then the load of 
cancer stem cells/undifferentiated transformed cells may increase 
and provide detectable tumors and facilitate invasion and tumor 
metastasis.
Maintenance of chronic inflammation and lack of adequate 
NK expansion could be one reason why cancer patients suffer 
from a number of oral diseases. In addition, loss of NK cell num-
bers due to their lack of expansion may occur long before the 
establishment of overt cancer, indicating that oral manifestations 
of inflammation can appear before the establishment of cancer 
FigUre 3 | Tail vein injection of super-charged NK cells with and without feeding with AJ2 reversed inhibition of IFN-γ and IL-8 secretion by the gingival cells of 
tumor-bearing BLT mice. Humanized-BLT (hu-BLT) mice were generated as shown in the figure (a). Reconstitution of human immune cells in blood, BM and spleen 
of hu-BLT mice was analyzed using human and mouse CD45 antibodies. Percentages of each of human and mouse CD45+ immune cells are shown in each 
respective quadrant (B). Gingival tissues were harvested from each group of mice and single-cell suspensions were prepared. Surface expression of human CD45, 
CD3, CD16, and CD56 were determined using flow cytometric analysis after staining with respective PE- and FITC-conjugated antibodies. Isotype control antibodies 
were used as control. One of three representative experiments is shown in the figure (c). Flow chart presents the experimental design using hu-BLT mice. Mice were 
orthotopically implanted with 1 × 106 of human oral or pancreatic tumor cells in the floor of the mouth or in the pancreas. One to two weeks after tumor implantation 
selected hu-BLT mice received 1.5 × 106 human or hu-BLT mice super-charged NK cells via tail vein injection. Mice were fed with AJ2 (5 billion/dose) two weeks 
before the tumor implantation and continued throughout the experimental period every 48 h (D). Four to five weeks after tumor implantation mice were sacrificed 
and gingival cells from tumor-bearing mice injected with NK cells and fed with and without AJ2 probiotic bacteria were dissociated and single-cell suspensions were 
prepared and treated with IL-2 (1,000 units/ml) and the levels of IFN-γ (n = 4) were determined in supernatants harvested after 7 days of culture using specific 
ELISAs (e). The fold increase in IFN-γ secretion from the gingival cells of each mouse groups namely, control, NK injected in tumor-bearing mice or NK injected in 
tumor-bearing mice and fed with AJ2 was calculated based on the amounts released from cells obtained from tumor-bearing mice only (F). To demonstrate that 
autologous NK cells show the same profiles of activation as the allogeneic NK cells among groups of mice, single-cell suspensions of gingival cells from tumor-
bearing hu-BLT mice injected with autologous super-charged NK cells and fed with and without AJ2 probiotic bacteria were treated with IL-2 (1,000 units/ml) and 
the levels of IFN-γ (n = 2) from the supernatants were determined after 7 days of culture using specific ELISAs (g). Single-cell suspensions of gingival cells from 
tumor-bearing mice injected with NK cells and fed with and without AJ2 probiotic bacteria were treated with IL-2 (1,000 units/ml) and the levels of IL-8 (n = 4) in the 
supernatants were determined after 7 days of cultures using multiplex array kit (h). Pancreatic tumors from tumor-bearing hu-BLT mice injected with NK cells with 
and without feeding with AJ2 were excised at the end of the experiment and tumor weights were determined (n = 3) (i). Gingival cells from oral tumor-bearing mice 
injected with NK cells and fed with and without AJ2 were treated with IL-2 (1,000 units/ml) and the levels of IFN-γ (n = 2) were determined in supernatants after 
7 days of culture using specific ELISAs (J).
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and may be used to predict systemic events before cancer occurs. 
In addition, loss of NK cell function is detrimental for the patients 
since NK  cells are known to kill and differentiate cancer stem 
cells (35).
At the cancerous stage, significant loss of IFN-γ secretion was 
observed in tumor-bearing hu-BLT mice, and injection of super-
charged NK cells restored IFN-γ secretion and the combination of 
NK and feeding with AJ2 probiotic bacteria significantly elevated 
IFN-γ secretion. Restoration of IFN-γ secretion in gingiva cor-
related with the ability of NK cells to eliminate tumor growth in 
the pancreas (manuscript submitted). Restoration of NK func-
tion by the injection of autologous or allogeneic NK cells had a 
similar effect (Figures 3E,G). In addition, injection of NK cells 
into tumor-bearing mice was responsible for the increase in 
the percentages of CD45+ immune cells and increased CD3+ 
T  cells. Indeed, NK  cells are crucial for the maintenance and 
increase in CD3+ T  cells (10). Therefore, well-established loss 
of NK cell numbers and function in a variety of cancers is not 
only detrimental for the control of tumors, since NK cells but not 
T cells target cancer stem cells, but also they will not be able to 
expand T cells (10). Interestingly, loss of NK cells not only occurs 
in the tumor microenvironment but it also occurs in the gingiva, 
therefore, the oral cavity may be a predictor of systemic events 
within and outside the tumor.
Depending on the tumor microenvironment, levels of tumor 
differentiation, and the extent of defect in NK cells and in cells 
which support their activation, different type and levels of 
functional loss of NK cells may be seen. Indeed, we have previ-
ously reported four stages of NK cell maturation and activation 
depending on the level and intensity of signaling NK cells receive 
(23). At stage 1, NK cells mediate increased cytotoxicity in the 
absence of cytokine secretion after receptor activation. At stage 
FigUre 4 | Increased percentages of CD45+and CD3+ T cells in gingiva of tumor-bearing mice injected with the NK cells and fed with AJ2. Gingiva from oral 
tumor-bearing mice injected with NK cells and fed with and without AJ2 were harvested and single-cell suspensions were prepared as described in the Section 
“Material and Methods.” Percentages of CD45+ and CD3+ T cells in gingiva in four groups of mice were determined using flow cytometric analysis after staining 
with the respective PEcy5-conjugated and FITC-conjugated antibodies. Isotype control antibodies were used as controls (a,B).
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2, cytotoxicity is suppressed but secretion of cytokines is induced 
which we have previously coined as split anergy in NK  cells 
responsible for the induction of tumor differentiation (23). At 
stage 3, both cytotoxicity and cytokine secretion are suppressed 
and at stage 4 a subset of NK cells are programmed to undergo 
cell death (23). Therefore, based on these stages it appears that 
NK  cells at the precancerous stage are in stage 2 of matura-
tion since cytotoxicity is suppressed but cytokine secretion is 
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